Login or create an accountClose
I am a returning customer
Login or create an accountClose
Your Account Has Been Created!
Thank you for registering with MedsDots!
You will be notified by e-mail once your account has been activated by the store owner.
If you have ANY questions about the operation of this online shop, please contact the store owner.
You have been logged off your account. It is now safe to leave the computer.
Your shopping cart has been saved, the items inside it will be restored whenever you log back into your account.
tagrisso 80mg azd9291 tablets astrazeneca
- Manufacturer ASTRAZENECA
- Product Code: Tagrisso 80mg Tablets
Brand Name: Tagrisso 80mg
Chemical Name: AZD9291
Active Ingredient: Osimertinib 80mg
Manufactured by: AstraZeneca PLC
Packing: Pack of 30 Tablets Country of Origin: Sweden
what is tagrisso (azd9291)?
osimertinib 80mg is the generic name for the trade drug tagrisso and its international brand name is tagrisso 80mg. in some cases, health care professionals may use the trade name tagrisso™ or azd9291 when referring to the generic drug name osimertinib or tagrisso. bengal osimertinib is a targeted therapy. tagrisso is an oral egfr kinase inhibitor. medsdots is offering a wide range of alternative osimertinib at your door steps with quality assurance guarantee. find azd9291 inhibitor at affordable and discounted price with medsdots.net who are providing worldwide shipment including china, hong kong, usa, uk, uae, russia, nigeria, bulgaria, singapore, malaysia, thailand, rwanda, switzerland, ukraine, poland, and many other countries. to get prices and more details like uses, dosage, side effects and precautions call us at whatsapp/viber or phone +91-9953810074, wechat or skype: medsdots, email: firstname.lastname@example.org, web: www.medsdots.net.
what azd9291 is used for:
tagrisso is used for the treatment of patients with metastatic epidermal growth factor receptor (egfr) t790m mutation-positive non-small cell lung cancer (nsclc), as detected by fda-approved test, who have progressed on or after egfr tkii therapy.
possible side effects of generic osimertinib 80mg:-
- most people do not experience all of the side effects listed.
- side effects are often predictable in terms of their onset and duration.
- side effects are almost always reversible and will go away after treatment is complete.
- there are many options to help minimize or prevent side effects.
- there is no relationship between the presence or severity of side effects and the effectiveness of the medication.
the following side effects are common (occuring in greater than 30%) for patients taking osimertinib:
decrease in white blood cells (total number; cells needed to fight infection), low platelets, anemia, diarrhea, skin rash, neutroipenia (decrease in neutrophils- a type of white blood cell), dry skin
these side effects are less common side effects (occuring in about 10-29%) of patients receiving osimertinib:
low sodium, nail changes, high magnesium levels, eye disorder (including dry eyes, blurred vision, keratitis, cataract, eye irritation, blepharitis, eye pain, increase tear production, floaters), nausea, decreased appetite, constipation, fatigue, cough, itching, back pain, mouth sores, headache.
precautions need to taken while consuming azd9291:
-before starting (indian azd9291) osimertinib treatment, make sure you tell your doctor about any other medications you are taking (including prescriptions, over-the-counter, vitamins, herbal remedies, etc.). do not take aspirin, or products containing aspirin unless your doctor specifically permits this.
-do not receive any kind of immunization or vaccination without your doctor's approval while taking generic tagrisso.
-inform your health care professional if you are pregnant or may be pregnant prior to starting this treatment. osimertinib may be hazardous to the fetus. women who are pregnant or become pregnant must be advised of the potential hazard to the fetus.
-for both men and women: do not conceive a child (get pregnant) while taking indian tagrisso. women of child bearing age should use effective contraception during therapy and for 6 weeks after the last dose of tagrisso . males should also use effective contraception during therapy and for 4 months after the last dose of tagrisso 80mg. discuss with your doctor when you may safely become pregnant or conceive a child after therapy.
-do not breast feed while taking this medication.